ZIPAN-50 Drug Patent Profile
✉ Email this page to a colleague
When do Zipan-50 patents expire, and when can generic versions of Zipan-50 launch?
Zipan-50 is a drug marketed by Altana and is included in one NDA.
The generic ingredient in ZIPAN-50 is promethazine hydrochloride. There are twelve drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zipan-50
A generic version of ZIPAN-50 was approved as promethazine hydrochloride by ZYDUS PHARMS USA on November 18th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZIPAN-50?
- What are the global sales for ZIPAN-50?
- What is Average Wholesale Price for ZIPAN-50?
Summary for ZIPAN-50
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 123 |
| Patent Applications: | 2,658 |
| DailyMed Link: | ZIPAN-50 at DailyMed |
US Patents and Regulatory Information for ZIPAN-50
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Altana | ZIPAN-50 | promethazine hydrochloride | INJECTABLE;INJECTION | 083997-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
